Home > Insider Trading > Filing (0000919574-19-000365)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534120	Cerecor Inc.	CERC	Pharmaceutical Preparations (2834)	450705648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1601086	Armistice Capital, Llc	510 Madison Avenue, 7Th Floor New York NY 10022		Yes	No	Yes	No
1706140	Steven Boyd	C/O Armistice Capital, Llc 510 Madison Avenue, 7Th Floor New York NY 10022		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-09	545	$3.79	18,156,348	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-10	800	$3.70	18,157,148	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-11	6,651	$3.91	18,163,799	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-11	2,500	$3.89	18,166,299	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-11	2,500	$3.88	18,168,799	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-11	421	$3.89	18,169,220	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-01-11	579	$3.92	18,169,799	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

The reported securities are directly owned by certain investment advisory clients of Armistice Capital, LLC ("Armistice Capital"), and may be deemed to be indirectly beneficially owned by Armistice Capital as the investment manager of such advisory clients. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital. Armistice Capital and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.